REFERENCES
- Holmgren L, O'Reilly M S, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1: 149–153, [PUBMED], [INFOTRIEVE]
- Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18–32, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9–22, [PUBMED], [INFOTRIEVE]
- Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001; 276: 3222–3230, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dvorak H F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20: 4368–4380, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tanigawa N, Amaya H, Matsumara M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997; 5: 826–832
- El-Assal O N, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998; 27: 1554–1562, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Salven P, Heikkila P, Anttonen A, et al. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997; 10: 1128–1133, [PUBMED], [INFOTRIEVE]
- Salven P, Manpaa H, Orpana A, et al. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res. 1997; 3: 647–651, [PUBMED], [INFOTRIEVE]
- Poon R TP, Fan S T, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001; 4: 1207–1225
- Tabone M D, Landman Parker J, Arcil B, et al. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?. Clin Canc Res. 2001; 7: 538–543
- Pavlakovic H, Von Schutz V, Rossler J, et al. Quantification of angiogenesis stimulators in children with solid malignancies. Int J Cancer. 2001; 92: 756–760, [PUBMED], [INFOTRIEVE], [CROSSREF]
- de Bont E S, Fidler V, Meeuwsen T, et al. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. Clin Cancer Res. 2002; 8: 2856–2861, [PUBMED], [INFOTRIEVE]
- Dvorak H F, Brown L F, Detmar M, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–1039, [PUBMED], [INFOTRIEVE]
- Bellamy W T, Richter L, Frutiger Y, Grogam T. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999; 59: 728–733, [PUBMED], [INFOTRIEVE]
- Verheul H M, Pinedo H M. Tumor growth: a putative role for platelets?. Oncologist 1998; 3: II, [PUBMED], [INFOTRIEVE]
- Yamamoto Y, Toi M, Kondo T, et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Can Res. 1997; 3: 647–651
- Poon R T, Lau C P, Cheung S T, et al. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res. 2003; 63: 3121–3126, [PUBMED], [INFOTRIEVE]
- Brattstrom D, Bergqvist M, Larsson A, et al. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res. 1998; 18: 1123–1127, [PUBMED], [INFOTRIEVE]
- Hyodo I, Doi T, Endo H, et al. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer. 1998; 34: 2041–2045, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hayes A J, Mostyn-Jones A, Koban M U, et al. Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg. 2004; 91: 242–247, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Niitsu N, Okamoto M, Nakamine H, et al. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma. Eur J Haematol. 2002; 68: 91–100, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Blann A D, Li J L, Kumar S. Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis. Cancer Lett 2001; 173: 183–186, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 2000; 95: 2637–2644, [PUBMED], [INFOTRIEVE]
- Hussong J W, Rodgers G M, Shami P. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313, [PUBMED], [INFOTRIEVE]
- Koomagi R, Zintl F, Sauerbrey A, Volm M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real time quantitative polymerase chain reaction. Clin Cancer Res. 2001; 7: 3381–3384, [PUBMED], [INFOTRIEVE]